VCM
ARRY

Vivaldi Capital Management’s Array Biopharma Inc ARRY Stock Holding History

Vivaldi Capital Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-6,738
Closed -$312K – 257
2019
Q2 		$312K Buy
+6,738
New +$189K 0.08% 180

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Vivaldi Capital Management's ARRY Position: Q3 2019 in Review

Vivaldi Capital Management sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 6,738 shares — an estimated $312K sold.

Vivaldi Capital Management first reported a position in ARRY in Q2 2019 and held it in 1 quarter. The position peaked at $312K in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Vivaldi Capital Management reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Vivaldi Capital Management sold 6,738 Array Biopharma Inc shares in Q3 2019, an estimated $312K.
  • Vivaldi Capital Management first reported a position in Array Biopharma Inc in Q2 2019 and held it in 1 quarter.
  • Vivaldi Capital Management's Array Biopharma Inc position peaked at $312K in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Vivaldi Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.